IGMIN: We're glad you're here. Please click 'create a new query' if you are a new visitor to our website and need further information from us.
If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click 'take me to my Query.'
Welcome to IgMin Research – an Open Access journal uniting Biology, Medicine, and Engineering. We’re dedicated to advancing global knowledge and fostering collaboration across scientific fields.
Welcome to IgMin, a leading platform dedicated to enhancing knowledge dissemination and professional growth across multiple fields of science, technology, and the humanities. We believe in the power of open access, collaboration, and innovation. Our goal is to provide individuals and organizations with the tools they need to succeed in the global knowledge economy.
IgMin Publications Inc., Suite 102, West Hartford, CT - 06110, USA
Our aim is to build bridges between fields to strengthen the pace of scientific advancements.
Biography
Dr. Cees Th. Smit Sibinga is a renowned expert in transfusion medicine with an extensive academic and professional background spanning several decades. He is affiliated with the University of Groningen and IQM Consulting in the Netherlands, where he plays a key role in the international development of safe and effective blood transfusion systems. His career has been dedicated to improving global health through the advancement of transfusion practices, policy development, and education.
At the University of Groningen, Dr. Smit Sibinga has been instrumental in shaping academic programs and mentoring the next generation of healthcare professionals in transfusion medicine. Through IQM Consulting, he advises governments, international organizations, and health institutions on the development of quality management systems in blood services, particularly in low- and middle-income countries.
As an author at IgMin Research, he contributes scholarly work that reflects his commitment to evidence-based practices, policy advocacy, and health systems strengthening. His publications often address the ethical, logistical, and scientific challenges in transfusion medicine, emphasizing sustainability, accessibility, and safety.
Based in the Netherlands, Dr. Smit Sibinga has also been actively involved in global initiatives led by the World Health Organization and other international bodies. His lifelong dedication to improving transfusion services worldwide has earned him widespread recognition and respect in the field of global health and clinical transfusion science.
Dr. Cees Th. Smit Sibinga continues to impact both academic and professional communities with his expertise, leadership, and unwavering commitment to advancing transfusion medicine globally.
Research Interest
Dr. Cees Th. Smit Sibinga’s research interests are rooted in transfusion medicine, with a strong emphasis on quality systems, patient safety, and the development of sustainable blood services worldwide. He focuses on the ethical, clinical, and organizational aspects of transfusion practices, particularly in low- and middle-income countries. His work addresses the implementation of quality management systems, regulatory frameworks, and policy development to ensure safe, effective, and equitable access to blood and blood components.
Dr. Smit Sibinga is also deeply involved in studying the impact of education and training on improving transfusion services, advocating for evidence-based guidelines, and strengthening healthcare infrastructures through international collaboration. His research extends to health systems development, disaster preparedness, and global health governance related to blood safety.
Open Access Policy refers to a set of principles and guidelines aimed at providing unrestricted access to scholarly research and literature. It promotes the free availability and unrestricted use of research outputs, enabling researchers, students, and the general public to access, read, download, and distribute scholarly articles without financial or legal barriers. In this response, I will provide you with an overview of the history and latest resolutions related to Open Access Policy.
With the development of safe blood supply and transfusion comes the introduction of quality as a culture, implemented through the introduction of a Quality System (QS) and Quality Management System (QMS). Often the idea is that– ‘when instructions are written (SOPs) a quality system is in place. Just follow the instructions, that is it.’ However, quality only partly depends on following instructions at the operational level. Generally not understood is the importance of designing and implementing a quality management system, b...ased on 5 key elements 1) organization and structure; 2) standards (technical and quality); 3) documentation - traceability and evidence; 4) education - continued teaching and training; 5) assessment - continued monitoring and evaluation.Development and implementation of an appropriate quality system and management were evaluated for 15 developing countries (2004-2020) in 4 WHO regions. Projects were based on a step-by-step introduction to the concept and principles of quality following a Quality Management Training (QMT) course – modular, interactive, with improvement score evaluation focused on comprehension and ownership of the teaching and training contents.For an optimal understanding of the values of quality in Transfusion Medicine (TM), a culture has to be created - ownership development, commitment to and implementation of the principles of fitness for purpose, and the supplier-producer-customer continuum.
0000-0002-0896-4168 
